Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer

Chandru Gajendran(Jubilant Life Sciences (India)), Sivanandhan Dhanalakshmi(University of Colorado Health)
PLoS ONE
January 3, 2023
Cited by 17


Related Papers